DEVELOPMENT AND OPTIMIZATION OF SOLID LIPID NANOPARTICLES OF DASATINIB USING DESIGN OF EXPERIMENTS: IN VITRO DRUGRELEASE AND IN-VIVO PHARMACOKINETIC STUDIES. INT J OF PHARMA RES BIOMED ANAL 2025, 14 (2), 85-105.